Sunny Deol’s upcoming crime drama Suryaa: Ant Se Aarambh Tak has landed in controversy before its theatrical release. The Indian Medical Association (IMA) has asked the Union Information and Broadcasting Ministry to review the film’s promotional content, raising concerns about its portrayal of corruption in the healthcare system and scenes involving violence against medical professionals.
The association believes that certain elements could create a misleading impression of doctors as a community and potentially undermine public confidence in healthcare services. The development has put the spotlight on the film’s central theme, which revolves around a father’s search for answers after a personal tragedy exposes alleged wrongdoing within the medical system.
Why Has the IMA Objected to Sunny Deol’s Suryaa?
In its communication to Union Information and Broadcasting Minister Ashwini Vaishnaw, the IMA expressed concern over what it described as the generalisation of corruption within the medical profession.
The association argued that while individual cases of medical misconduct and unethical practices must be investigated and punished, the actions of a few should not damage the reputation of doctors who perform their duties honestly.
The IMA also raised objections to scenes depicting physical assaults on doctors, nurses and hospital staff. According to the association, portraying such attacks as heroic or justified could risk normalising violence against healthcare workers.
The organisation has called for an impartial review of the film’s content and appropriate corrective measures if necessary. It has also asked authorities to consider a ban or other action if justified under applicable law.
IMA Raises Concerns About Doctors’ Safety
The association’s objections extend beyond the film’s depiction of medical corruption. It has warned that promotional material appearing to glorify violence against healthcare professionals could contribute to hostility towards people working in hospitals.
Doctors and medical staff already face safety challenges in healthcare settings. The IMA believes that entertainment content should be handled responsibly when it involves violence against professionals providing essential services.
Another concern is the potential impact on the doctor-patient relationship. Trust and cooperation between patients and medical professionals are important for effective treatment, and the association fears that broad negative portrayals could weaken that relationship.
The IMA has clarified that its objections do not amount to support for unethical medical practices. It maintains that genuine cases of negligence, corruption or professional misconduct should be dealt with through appropriate legal and disciplinary procedures.
What Is Sunny Deol’s Suryaa: Ant Se Aarambh Tak About?
Directed by M. Padmakumar, Suryaa: Ant Se Aarambh Tak is an upcoming Hindi crime thriller starring Sunny Deol in the lead role.
The film’s teaser introduces a character dealing with a devastating personal loss who begins investigating disturbing developments connected to the medical system. What initially appears to be a personal search for answers gradually points towards a wider network of alleged wrongdoing.
Sunny Deol’s character challenges a system he believes has failed ordinary people. The story explores themes of grief, justice, accountability and alleged corruption in healthcare.
The film is an official remake of the 2018 Malayalam crime thriller Joseph. The Hindi adaptation features a supporting cast that includes Ravi Kishan, Pragya Jaiswal, Tanushree Chakraborty, Manish Wadhwa, Tinu Anand and Jisshu Sengupta.
Produced by Kamal Mukut, the film is scheduled to release in theatres on November 20, 2026.
Has the Film Been Banned or Cleared by the CBFC?
Despite the controversy, it is important to distinguish between the IMA’s request for a review and an official decision concerning the film’s release.
According to reports published on October 22, the Central Board of Film Certification (CBFC) clarified that Suryaa: Ant Se Aarambh Tak had not been submitted for certification at that time. Therefore, the IMA’s objection should not be interpreted as a confirmed ban or a certification rejection.
The association has requested that the authorities examine the promotional content and consider appropriate action. Any decision about certification, modifications or restrictions would depend on the relevant authorities and applicable law.
Suryaa Controversy Puts Creative Freedom in Focus
The dispute has reignited a broader debate about how films portray sensitive professions and social institutions. Filmmakers often use corruption and institutional failure as dramatic themes, while professional organisations may worry about the wider implications of such portrayals.
The challenge is to balance creative expression with concerns about public trust and the safety of people working in essential services.
For now, Suryaa remains scheduled for a November 20 theatrical release. Whether the IMA’s concerns lead to changes in the promotional material or other official action remains to be seen.
Click here for the latest news from Bollywood, Hollywood, South Film Industry, Bhojpuri and TV world… Click here to join the Facebook Page, Twitter Page, YouTube page, and Instagram of Bollywood Mascot!
Leave a Comment